OVIT — OncoVista Innovative Therapies Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $1.54m
Annual cashflow statement for OncoVista Innovative Therapies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2010 December 31st | 2011 December 31st | 2012 December 31st | 2013 December 31st | 2014 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 10 | -2.03 | -1.63 | -1.45 | -2.54 |
| Depreciation | |||||
| Non-Cash Items | -10.2 | 0.056 | -0.206 | -0.067 | -0.009 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.424 | 0.354 | 0.274 | 1.05 | 2.32 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.555 | -1.61 | -1.55 | -0.467 | -0.232 |
| Capital Expenditures | 0 | -0.003 | 0 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 5.92 | 0.204 | 0 | 0 | 0 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 5.92 | 0.202 | 0 | 0 | 0 |
| Financing Cash Flow Items | -1.11 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.97 | 0.008 | -0.06 | 0 | 0.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.42 | -1.4 | -1.61 | -0.467 | -0.032 |